Stock A009300 SAM-A PHARM. CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sam-A Pharm. Co., Ltd

Equities

A009300

KR7009300005

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 23/05/2024 am IST 		5-day change 1st Jan Change
18,840 KRW +0.69% Intraday chart for Sam-A Pharm. Co., Ltd +0.43% +14.88%
2023 Sam-A Pharm. Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 96,433 97,348 1,01,010 1,18,100 1,01,621 1,00,095
Enterprise Value (EV) 1 50,448 55,904 43,862 70,102 22,380 32,660
P/E ratio 11 x 9.55 x 828 x 34.8 x 8.53 x 4.68 x
Yield 1.58% 1.88% 1.81% 1.29% 2.4% 4.57%
Capitalization / Revenue 1.44 x 1.36 x 1.88 x 2.16 x 1.24 x 1.03 x
EV / Revenue 0.75 x 0.78 x 0.82 x 1.28 x 0.27 x 0.34 x
EV / EBITDA 4.24 x 3.83 x 5.61 x 7.19 x 1.04 x 1.19 x
EV / FCF - 48,00,573 x 66,26,816 x 59,66,798 x 12,67,429 x 33,90,161 x
FCF Yield - 0% 0% 0% 0% 0%
Price to Book 0.6 x 0.58 x 0.61 x 0.69 x 0.56 x 0.5 x
Nbr of stocks (in thousands) 6,103 6,103 6,103 6,103 6,103 6,103
Reference price 2 15,800 15,950 16,550 19,350 16,650 16,400
Announcement Date 12/03/20 12/03/20 22/03/21 17/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 66,947 71,560 53,653 54,666 81,700 97,211
EBITDA 1 11,899 14,604 7,821 9,747 21,440 27,395
EBIT 1 9,361 10,397 3,930 6,048 18,253 23,500
Operating Margin 13.98% 14.53% 7.33% 11.06% 22.34% 24.17%
Earnings before Tax (EBT) 1 11,489 13,051 1,573 5,335 18,400 28,476
Net income 1 8,801 10,197 123.9 3,392 11,912 21,374
Net margin 13.15% 14.25% 0.23% 6.2% 14.58% 21.99%
EPS 2 1,442 1,671 20.00 555.7 1,952 3,502
Free Cash Flow - 11,645 6,619 11,749 17,658 9,634
FCF margin - 16.27% 12.34% 21.49% 21.61% 9.91%
FCF Conversion (EBITDA) - 79.74% 84.63% 120.53% 82.36% 35.17%
FCF Conversion (Net income) - 114.2% 5,344.12% 346.41% 148.24% 45.07%
Dividend per Share 2 250.0 300.0 300.0 250.0 400.0 750.0
Announcement Date 12/03/20 12/03/20 22/03/21 17/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 45,985 41,444 57,148 47,998 79,241 67,435
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - 11,645 6,619 11,749 17,658 9,634
ROE (net income / shareholders' equity) - 6.2% 0.07% 2% 6.76% 11.2%
ROA (Net income/ Total Assets) - 3.57% 1.32% 2.04% 5.82% 6.76%
Assets 1 - 2,85,982 9,401 1,66,562 2,04,843 3,16,154
Book Value Per Share 2 26,363 27,550 27,245 28,185 29,593 32,846
Cash Flow per Share 2 3,674 2,130 3,014 1,308 1,503 1,478
Capex 1 2,398 492 680 275 239 3,820
Capex / Sales 3.58% 0.69% 1.27% 0.5% 0.29% 3.93%
Announcement Date 12/03/20 12/03/20 22/03/21 17/03/22 22/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SAM-A PHARM. CO., LTD Stock Sam-A Pharm. Co., Ltd
+14.88% 83.6M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.71% 44.35B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.44% 15.08B
CIPLA LIMITED Stock Cipla Limited
+19.49% 14.37B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+57.58% 13.06B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.43% 6.75B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.55% 5.64B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT. Stock Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
+4.00% 4.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A009300 Stock
  4. Financials Sam-A Pharm. Co., Ltd